|
1 Jin HZ, Huang DM, Guan XJ, ed. Practical neonatology. Beijing: People's Medical Publishing House, 2003, 230–231.[金汉珍，黄德珉，官希吉，主编．实用新生儿学．北京：人民卫生出版社，2003, 230–231.]
|
|
2 Zhang XF, Dong XM, Ye HM. The study progress in primary apnea of preterm infants. Foreign Med Sci Sect Pediatr, 2004, 3(31): 134–135.[张雪峰，董笑梅，叶鸿瑁．早产儿原发性呼吸暂停研究进展．国外医学儿科分册，2004，3(31)：134–135.]
|
|
3 Lu LL. The new progress in clinical intervention for premature infant apnea. J Clin Nurs, 2007, 4(6): 59.[陆琳琳．早产儿呼吸暂停的临床干预的新进展．临床护理杂志，2007，4(6)：59.]
|
|
4 Xu JP, Huang WY, Wang XY. A clinical observation of aminophylline in preventing the apnea of very low birth weight infant. J Pract Pharm, 2006, 5(12)：15.[徐决平，黄文玉，王晓燕．氨茶碱预防极低出生体重儿呼吸暂停的临床观察．儿科药学杂志，2006，5(12)：15.]
|
|
5 Yuan XW, Gao HB. Therapeutic effect of different ways on treatment of premature infants with apnea. J Pract Diagn Ther, 2007, 5(21): 347.[袁显文，高海波．不同方法治疗早产儿原发性呼吸暂停疗效观察．实用诊断与治疗杂志，2007, 5(21): 347.]
|
|
6 Zhang JX, Wei KL, Xue XD, ed. Neonate emergency medicine. Beijing: People's Medical Publishing House, 2001, 377–378.[张家骧，魏克伦，薛辛东，主编. 新生儿急救学. 北京：人民卫生出版社，2001，377–378.]
|
|
7 Cheng L, Li YX. Observation of therapeutic effect of naloxone united aminophylline used in treatment of premature infants with apnea. Matern Child Health Care China, 2005, 13(20)：1611.[成玲，黎浴曦．纳络酮联合氨茶碱治疗早产儿呼吸暂停的疗效观察. 中国妇幼保健，2005, 13(20): 1611.]
|
|
8 Lu ZQ, Zhang XL, Lin ZD, et al. The mechanism of plasma β endorphin in primary apnea of premature infants. Chin J Pediatr, 1999, 37(2)：76. [陆中权，张兴良，林忠东，等．早产儿原发性呼吸暂停血浆β–内啡肽作用机制探讨．中华儿科杂志，1999, 37(2)：76.]
|
|
9 Zhang XF, Dong XM, Ye HM. Plasma beta–endorphin concentration and Naloxone treatment in primary apnea of prematurity. Pediatr Emerg Med, 2004, 11(6): 376–378.[张雪峰，董笑梅，叶鸿瑁. β–内啡肽在早产儿原发性呼吸暂停发病中的作用及纳络酮疗效观察．小儿急救医学，2004，11(6)：376–378.]
|
|
10 Tang YM, Chen JM, Zhang L. Observations on the therapeutic effects of naloxone combination with aminofilina in the pretreatment of primary premature infant apnea. Acta Academ Med Militaris Tertiae, 2007, 23(29): 2291.[唐元明，趁金梅，张琳. 纳络酮与氨茶碱联合用药预防早产儿原发性呼吸暂停的疗效观察．第三军医大学学报，2007, 23(29): 2291.]
|
|
11 Zhu YM. The application of Naloxone in pediatrics emergency treatment. Chin J Pract Pediatr, 1999, 11(14): 346.[祝益民. 纳络酮在儿科急救中的应用．中国实用儿科杂志，1999, 11(14): 346.]
|
|
12 Li T, Liu B, Wang XH. Observations on the therapeutic effects of Naloxone in the treatment of premature infant apnea. Matern Child Health Care China, 2005, 15(20): 1948.[李彤，刘冰，王秀华. 纳络酮治疗早产儿呼吸暂停疗效观察．中国妇幼保健，2005，15(20)：1948.]
|
|
13 Ji BP. The clinical application and common side effect of Naloxone. J Commun Med, 2006, 8(4)：27.[纪宝平. 纳络酮的临床应用及常见副作用．社区医学杂志，2006, 8(4)：27.]
|
|
14 Meng QL. The application of Naloxone in emergency treatment. Chin J Critical Care Med, 2001, 21(2)：119–120.[孟庆林. 纳络酮在危重症中的应用．中国急救医学，2001, 21(2)：119–120.]
|
|
15 Qian PD, Zhang SD. The application of Naloxone in newborn infant disease. Chin J Pract Pediatr, 2001, 3(16)：183–184.[钱培德，张少丹. 纳络酮在新生儿疾病中的应用．中国实用儿科杂志，2001，3(16)：183.]
|